VGX-100

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVGX-100
Drug Alias NameVGX-100
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionVascular endothelial growth factor C inhibitors
TargetsVascular endothelial growth factor C
Therapy Area/IndicationsSolid tumoursEye DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVegenics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVegenicsCeres OncologyOpthea Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsSolid tumoursEye DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A